News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
719,186 Results
Type
Article (42541)
Company Profile (294)
Press Release (676351)
Multimedia
Podcasts (80)
Webinars (12)
Section
Business (210471)
Career Advice (2091)
Deals (36636)
Drug Delivery (107)
Drug Development (83078)
Employer Resources (175)
FDA (16585)
Job Trends (15415)
News (356116)
Policy (33931)
Tag
Academia (2599)
Accelerated approval (5)
Adcomms (21)
Allergies (90)
Alliances (51448)
ALS (95)
Alzheimer's disease (1401)
Antibody-drug conjugate (ADC) (137)
Approvals (16586)
Artificial intelligence (273)
Autoimmune disease (24)
Automation (16)
Bankruptcy (371)
Best Places to Work (11771)
BIOSECURE Act (20)
Biosimilars (112)
Biotechnology (188)
Bladder cancer (78)
Brain cancer (29)
Breast cancer (289)
Cancer (2333)
Cardiovascular disease (188)
Career advice (1753)
Career pathing (31)
CAR-T (154)
Cell therapy (437)
Cervical cancer (20)
Clinical research (67609)
Collaboration (870)
Company closure (1)
Compensation (558)
Complete response letters (25)
COVID-19 (2662)
CRISPR (47)
C-suite (257)
Cystic fibrosis (105)
Data (2287)
Decentralized trials (2)
Denatured (28)
Depression (47)
Diabetes (279)
Diagnostics (6459)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (124)
Drug pricing (113)
Drug shortages (28)
Duchenne muscular dystrophy (96)
Earnings (88495)
Editorial (39)
Employer branding (21)
Employer resources (149)
Events (115424)
Executive appointments (750)
FDA (17925)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (772)
Gene editing (116)
Generative AI (21)
Gene therapy (325)
GLP-1 (754)
Government (4543)
Grass and pollen (5)
Guidances (108)
Healthcare (19008)
Huntington's disease (25)
IgA nephropathy (28)
Immunology and inflammation (129)
Indications (30)
Infectious disease (2807)
Inflammatory bowel disease (147)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (99)
Interviews (323)
IPO (16796)
IRA (47)
Job creations (4059)
Job search strategy (1492)
Kidney cancer (10)
Labor market (40)
Layoffs (494)
Leadership (18)
Legal (8381)
Liver cancer (77)
Lung cancer (326)
Lymphoma (157)
Machine learning (8)
Management (59)
Manufacturing (333)
MASH (72)
Medical device (13467)
Medtech (13472)
Mergers & acquisitions (20397)
Metabolic disorders (722)
Multiple sclerosis (81)
NASH (17)
Neurodegenerative disease (97)
Neuropsychiatric disorders (29)
Neuroscience (1966)
NextGen: Class of 2025 (6637)
Non-profit (4528)
Now hiring (40)
Obesity (385)
Opinion (229)
Ovarian cancer (78)
Pain (102)
Pancreatic cancer (89)
Parkinson's disease (151)
Partnered (21)
Patents (246)
Patient recruitment (116)
Peanut (49)
People (59320)
Pharmaceutical (91)
Pharmacy benefit managers (20)
Phase I (20974)
Phase II (29749)
Phase III (22289)
Pipeline (1290)
Policy (156)
Postmarket research (2654)
Preclinical (8936)
Press Release (68)
Prostate cancer (108)
Psychedelics (31)
Radiopharmaceuticals (251)
Rare diseases (399)
Real estate (6258)
Recruiting (67)
Regulatory (23178)
Reports (46)
Research institute (2369)
Resumes & cover letters (358)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (78)
Series A (133)
Series B (88)
Service/supplier (12)
Sickle cell disease (55)
Special edition (15)
Spinal muscular atrophy (150)
Sponsored (30)
Startups (3729)
State (2)
Stomach cancer (14)
Supply chain (69)
Tariffs (49)
The Weekly (50)
Vaccines (714)
Venture capitalists (41)
Weight loss (255)
Women's health (35)
Worklife (16)
Date
Today (292)
Last 7 days (862)
Last 30 days (2944)
Last 365 days (33155)
2025 (11472)
2024 (35781)
2023 (40636)
2022 (51802)
2021 (56330)
2020 (54795)
2019 (47399)
2018 (35771)
2017 (33140)
2016 (32662)
2015 (38617)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30489)
2010 (28497)
Location
Africa (782)
Alabama (53)
Alaska (7)
Arizona (239)
Arkansas (14)
Asia (40758)
Australia (6523)
California (6300)
Canada (2052)
China (547)
Colorado (272)
Connecticut (276)
Delaware (157)
Europe (87057)
Florida (932)
Georgia (208)
Idaho (57)
Illinois (558)
India (26)
Indiana (322)
Iowa (11)
Japan (171)
Kansas (104)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (917)
Massachusetts (4736)
Michigan (224)
Minnesota (398)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (65)
New Hampshire (63)
New Jersey (1779)
New Mexico (29)
New York (1786)
North Carolina (1000)
North Dakota (8)
Northern California (2758)
Ohio (207)
Oklahoma (14)
Oregon (39)
Pennsylvania (1413)
Puerto Rico (12)
Rhode Island (33)
South America (1163)
South Carolina (25)
South Dakota (1)
Southern California (2364)
Tennessee (103)
Texas (942)
United States (23808)
Utah (187)
Virginia (159)
Washington D.C. (64)
Washington State (565)
West Virginia (3)
Wisconsin (59)
719,186 Results for "osi pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
OSI Systems Reports Fiscal 2024 Third Quarter Financial Results
OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced its financial results for the three and nine months ended March 31, 2024.
April 25, 2024
·
15 min read
Biotech Beach
OSI Systems Receives $5 Million Award for Patient Monitoring Solutions
OSI Systems, Inc. announced that its Healthcare division, Spacelabs Healthcare®, has received an order valued at approximately $5 million to provide patient monitoring solutions and related supplies and accessories to a U.S. based hospital.
January 4, 2024
·
2 min read
Business
OSI Systems Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results
OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced its financial results for the fourth quarter and fiscal year ended June 30, 2023.
August 24, 2023
·
15 min read
Biotech Beach
OSI Systems Receives $4 Million Award for Patient Monitoring Systems
OSI Systems, Inc. announced that its Healthcare division, Spacelabs Healthcare®, has received an order valued at approximately $4 million to provide patient monitoring solutions and related accessories to a U.S. based hospital.
October 30, 2023
·
2 min read
Biotech Beach
OSI Systems Receives $15 Million Order for Airport Screening Systems - November 09, 2023
OSI Systems, Inc. announced that its Security division received an international order for approximately $15 million to provide multiple units of its various checkpoint screening solutions.
November 9, 2023
·
2 min read
Press Releases
Nika Pharmaceuticals, Inc. (NIKA) Latest Developments
April 14, 2025
·
2 min read
Business
OSI Systems Announces Third Quarter Conference Call
OSI Systems, Inc. (Nasdaq: OSIS) today announced that it will hold its quarterly conference call on Thursday, April 27, 2023 at 9:00am PT to discuss its results for the quarter ended March 31, 2023.
April 17, 2023
·
1 min read
Press Releases
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Investor Event at Mar-A-Lago Club on May 8, 2025
May 7, 2025
·
5 min read
Press Releases
Universe Pharmaceuticals INC Announces Share Consolidation
March 20, 2025
·
3 min read
Press Releases
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Complete Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America
May 1, 2025
·
7 min read
1 of 71,919
Next
